1. Acute amnestic encephalopathy in amyloid-β oligomer–injected mice is due to their widespread diffusion in vivo.
- Author
-
Epelbaum, Stéphane, Youssef, Ihsen, Lacor, Pascale N., Chaurand, Pierre, Duplus, Eric, Brugg, Bernard, Duyckaerts, Charles, and Delatour, Benoît
- Subjects
- *
ALZHEIMER'S disease diagnosis , *AMNESIA , *AMYLOID beta-protein , *OLIGOMERS , *INJECTIONS , *BIOMARKERS , *LABORATORY mice - Abstract
Amyloid-β (Aβ) oligomers are the suspected culprit as initiators of Alzheimer's disease (AD). However, their diffusion in the brain remains unknown. Here, we studied Aβ oligomers' dissemination and evaluated their in vivo toxicity. Wild-type mice were injected with 50 pmol of synthetic Aβ oligomers (of different size) in the hippocampus. Oligomers diffused largely in the brain as soon as 1 hour and up to 7 days after injection. A transient encephalopathy with memory impairment was induced by this unique injection. The immunoreactivity of the postsynaptic marker PSD95 was diffusely decreased. Similar results (both on memory and PSD95 immunoreactivity) were obtained with delipidated and high molecular weight oligomers (>50 kDa) but not with smaller assemblies. Tau hyperphosphorylation was observed in the oligomer-injected brains. Finally, fos immunostaining was increased in Aβ-derived diffusible ligands–injected mice, suggesting neuronal hyperactivity. Rapid and widespread diffusion of Aβ oligomers was demonstrated in vivo and associated with decreased synaptic markers and memory deficits which gives new insight to the pathogenicity of Aβ. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF